Oxford Finance LLC

Oxford’s Enterprise Lending Team proudly announces the closing of a debt financing agreement for up to $275 million with Orthofix Medical Inc. Orthofix is a global medical technology company that offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics, and enabling technologies, including the 7D FLASH? navigation system, that heal musculoskeletal pathologies. Proceeds from the financing will be used to refinance Orthofix’s existing debt facility and to support long-term, profitable growth. Link to Press Release: https://lnkd.in/eSK6VnxA

Oxford’s Leveraged Lending Team is pleased to announce the closing of a senior credit facility with SkinCure Oncology, in support of its partnership with H.I.G. Capital. Oxford Finance served as Lead Arranger, Administrative Agent, & Bookrunner on the transaction. Headquartered in Burr Ridge, IL, SkinCure Oncology provides its physician partners with a comprehensive model for the delivery of IG-SRT for the treatment of nonmelanoma skin cancer.

Oxford’s Leveraged Lending Team is pleased to announce the closing of a senior credit facility with Oxford Road and Veritone One in support of its partnership with Insignia Capital Group. The combined platform will create a leading audio and creator-based advertising agency which will transform how brands leverage audio and creator-led content to drive measurable results. The transaction unites Oxford Road’s international traction and industry innovation with Veritone One’s advanced technology stack, data capabilities, and creator-led video and influencer expertise.

Oxford’s Enterprise Lending Team is pleased to announce the closing of a debt financing agreement for up to $35 million with Koya Medical, Inc. Koya is commercializing Dayspring, the first portable integrative compression treatment for venous and lymphatic disorders, which affect more than 20 million patients in the US. Proceeds from the financing will be used to refinance Koya’s existing debt facility, support the continued expansion of Dayspring, and accelerate the development of Koya’s innovative pipeline aimed at improving vascular care.

Oxford’s Enterprise Lending Team is pleased to announce the closing of a debt financing agreement of up to $50 million with?Opentrons Labworks Inc.?and its wholly owned subsidiary,?Neochromosome, Inc.. Opentrons is a leader in lab automation, providing thousands of institutions with flexible, easy-to-use lab robots that automate R&D operations and experiments, while Neochromosome unlocks previously unapproachable research with its groundbreaking synthetic DNA and cell engineering services. Proceeds from the transaction will go towards accelerating the commercialization of Opentrons’ next-generation robot, the Opentrons Flex, and towards further R&D by Neochromosome.

Oxford Finance will be attending HLTH USA 2024 in Las Vegas from October 20-23. If you are planning to attend, please reach out directly to one of our team members to connect - Christopher Herr, David Hickman, Garrett H.. Oxford provides senior secured ARR and venture loans to private and public digital health, life sciences, SaaS, and tech-enabled services companies. We welcome the opportunity to explore how we can support your growth and financing needs. ? #HLTH2024 #HLTHUSA #digitalhealth #healthtech #saas #lifesciences #enterpriselending #bebold #healthcare #healthinnovation #futureofhealth

Oxford’s Leveraged Lending Team is pleased to announce the closing of a senior credit facility with Irrimax Corporation, in support of its partnership with ARCHIMED.?Lawrenceville, Georgia-based Irrimax, founded in 2003, develops and markets Irrisept? Antimicrobial Wound Lavage, a market-leading solution within high performance wound irrigation.

Oxford's Real Estate & ABL Team is pleased to announce the closing of a $47 million senior credit facility with Creative Solutions In HealthCare.?Funds drawn at closing were used to finance the acquisition of two skilled nursing facilities in Texas, totaling 228 beds. Additionally, the credit facility includes a substantial delayed draw commitment, providing Creative Solutions with the flexibility to finance future acquisitions. Creative Solutions In HealthCare is a family-owned company, headquartered in Fort Worth, TX, with more than 170 long-term care communities throughout the state of Texas. The Company’s fundamental goal is to provide the highest quality of care to the Greatest Generation.

Oxford’s Leveraged Lending Team is pleased to announce the closing of a senior credit facility with?Kashi Clinical Laboratories, in support of its partnership with?Prairie Capital. The Company was founded in 2006 to provide high-resolution HLA typing for transplant donor matching. Over time, Kashi expanded its service offering to include post-transplant monitoring, genomic sequencing, and other diagnostic testing. Kashi enjoys industry-leading customer satisfaction and is renowned for its rapid turnaround time, scientific expertise, customer service and innovation using state-of-the-art technology. ?

Oxford Finance is pleased to announce the appointment of David Hickman and Garrett Henn as Co-Heads of Oxford’s enterprise lending division, which includes life sciences, healthtech, and SaaS. David and Garrett collectively bring over four decades of lending expertise to their new leadership roles at Oxford, specializing in loan structuring and portfolio management for public and private life sciences, healthtech, and SaaS companies. View Full Press Release - https://shorturl.at/rPidJ